PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
226.57%
Net income growth above 1.5x CNQ's 87.06%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
-48.89%
Negative yoy D&A while CNQ is 10.81%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
1240.68%
Well above CNQ's 65.57% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
98.30%
Slight usage while CNQ is negative at -67.58%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
100.00%
Some yoy usage while CNQ is negative at -67.58%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-23.02%
Both negative yoy, with CNQ at -233.97%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
21.05%
Some CFO growth while CNQ is negative at -17.80%. John Neff would note a short-term liquidity lead over the competitor.
18.58%
Some CapEx rise while CNQ is negative at -116.73%. John Neff would see competitor possibly building capacity while we hold back expansions.
-155.78%
Both yoy lines negative, with CNQ at -100.00%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
168.74%
Purchases growth of 168.74% while CNQ is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-162.53%
We reduce yoy sales while CNQ is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-157.56%
We reduce yoy other investing while CNQ is 510.55%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
365.10%
We have mild expansions while CNQ is negative at -37.46%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
17.77%
We repay more while CNQ is negative at -221.05%. John Neff notes advantage in lowering leverage if competitor is ramping up debt or repaying less.
227.31%
Stock issuance far above CNQ's 83.54%. Michael Burry flags a significant dilution risk vs. competitor’s approach unless ROI is very high.
-186831.83%
We cut yoy buybacks while CNQ is 75.35%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.